Home/Filings/4/0001179110-18-001861
4//SEC Filing

Vetticaden Santosh 4

Accession 0001179110-18-001861

CIK 0001005201other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:14 PM ET

Size

5.6 KB

Accession

0001179110-18-001861

Insider Transaction Report

Form 4
Period: 2018-02-06
Vetticaden Santosh
SVP, Chief Medical Officer ***
Transactions
  • Award

    Restricted Stock Units

    2018-02-06+36,80036,800 total
    Common Stock (36,800 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F2]These restricted stock units are scheduled to vest 33.33% on February 6, 2019, 33.33% on February 6, 2020 and 33.33% on February 6, 2021, assuming continued employment through the applicable vesting date.

Issuer

DEPOMED INC

CIK 0001005201

Entity typeother

Related Parties

1
  • filerCIK 0001386932

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:14 PM ET
Size
5.6 KB